INTERNATIONAL PATENT: SHANGHAI APEIRON THERAPEUTICS COMPANY LIMITED, 上海湃隆生物科技有限公司 FILES APPLICATION FOR "USE OF PRMT5 INHIBITOR IN TREATMENT OF TUMORS OR CANCERS"

GENEVA, April 19 -- SHANGHAI APEIRON THERAPEUTICS COMPANY LIMITED (Unit C101, 1976 Gaoke Zhong Road, Pilot Free Trade, Pudong New AreaShanghai 201210), 上海湃隆生物科技有限公司 (中国上海市浦东新区中国（上海）自由贸易试验区高科中路1976号1幢C101室) filed a patent application (PCT/CN2024/124325) for "USE OF PRMT5 INHIBITOR IN TREATMENT OF TUMORS OR CANCERS" on Oct 12, 2024. With publication no. WO/2025/077857, the details related to the patent application was published on Apr 17, 2025.

Notably, the pa...